Tag Archive for: hematology

With the settlement of a big acquisition behind them and a strong portfolio of therapeutics that continues to expand, hopes for smooth sailing are on the horizon.

As with the Massachusetts layoffs announced two weeks ago, a Takeda spokesperson stated that the cuts in California are directly related to the company’s decision to discontinue discovery and pre-clinical efforts in AAV gene therapy as well as research and pre-clinical efforts in rare hematology. 

As the healthcare journey for patients living with cancer has changed, so has the way in which pharmaceutical companies bring a drug to market. Med Ad News spoke with Anne Marie Robertson, SVP, strategy & marketing, EVERSANA about how companies need to rethink traditional commercialization models in oncology to be agile in today’s market.

Merck initiated a tender offer Monday to buy all outstanding shares of Imago Biosciences. This follows the November announcement of the buyout.

After eight years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates the agency’s continued focus on client service, operational excellence, and healthy growth.

The company is touting the platform as the first fully digital clinical trial solution for oncology, hematology, and urology.